Literature DB >> 10488163

Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania.

M M Navia1, L Capitano, J Ruiz, M Vargas, H Urassa, D Schellemberg, J Gascon, J Vila.   

Abstract

Eighty-six strains of Shigella spp. were isolated during the dry season from stool samples of children under 5 years of age in Ifakara, Tanzania. The epidemiological relationship as well as the antimicrobial susceptibility and mechanisms of resistance to ampicillin, chloramphenicol, and co-trimoxazole were investigated. Four different epidemiological tools, pulsed-field gel electrophoresis (PFGE), repetitive extragenic palindromic (REP)-PCR, plasmid analysis, and antibiogram, were compared for typing Shigella strains. Seventy-eight (90%) strains were Shigella flexneri and were distributed into four groups, by either PFGE or REP-PCR, with 51, 17, 7, and 3 strains. The four strains of Shigella dysenteriae belonged to the same group, and the four strains of Shigella sonnei were distributed in two groups with three and one strain each. Plasmid analysis showed a high level of heterogeneity among strains belonging to the same PFGE group, while the antibiogram was less discriminative. REP-PCR provided an alternative, rapid, powerful genotyping method for Shigella spp. Overall, antimicrobial susceptibility testing showed a high level of resistance to ampicillin (81.8%), chloramphenicol (72.7%), tetracycline (96.9%), and co-trimoxazole (87.9%). Ampicillin resistance was related to an integron-borne OXA-1-type beta-lactamase in 85.1% of the cases and to a TEM-1-type beta-lactamase in the remaining 14.8%. Resistance to co-trimoxazole was due to the presence of a dhfr Ia gene in all groups except one of S. flexneri, where a dhfr VII gene was found within an integron. Chloramphenicol resistance was associated in every case with positive chloramphenicol acetyltransferase activity. All strains were susceptible to nalidixic acid, ciprofloxacin, ceftazidime, cefotaxime, and cefoxitin. Therefore, these antimicrobial agents may be good alternatives for the treatment of diarrhea caused by Shigella in Tanzania.

Entities:  

Mesh:

Year:  1999        PMID: 10488163      PMCID: PMC85506          DOI: 10.1128/JCM.37.10.3113-3117.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers.

Authors:  R V Tauxe; N D Puhr; J G Wells; N Hargrett-Bean; P A Blake
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods.

Authors:  P Y Liu; Y J Lau; B S Hu; J M Shyr; Z Y Shi; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

3.  The type VII dihydrofolate reductase: a novel plasmid-encoded trimethoprim-resistant enzyme from gram-negative bacteria isolated in Britain.

Authors:  S G Amyes; K J Towner; G I Carter; C J Thomson; H K Young
Journal:  J Antimicrob Chemother       Date:  1989-08       Impact factor: 5.790

Review 4.  Antibiotic resistance in developing countries.

Authors:  W E Farrar
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

5.  Antimicrobial resistance of Shigella isolates causing traveler's diarrhea.

Authors:  J Vila; J Gascon; S Abdalla; J Gomez; F Marco; A Moreno; M Corachan; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  Molecular epidemiology of Shigella infections: plasmid profiles, serotype correlation, and restriction endonuclease analysis.

Authors:  C M Litwin; A L Storm; S Chipowsky; K J Ryan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

7.  Electropherotyping of plasmid DNA of different serotypes of Shigella flexneri isolated in Bangladesh.

Authors:  K Haider; M I Huq; K A Talukder; Q S Ahmad
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

8.  Molecular epidemiology of plasmid patterns in Shigella flexneri types 1-6.

Authors:  A Gebre-Yohannes; B S Drasar
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

9.  Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases.

Authors:  C C Simonsen; E Y Chen; A D Levinson
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

10.  Characterization of plasmids from antibiotic-resistant Shigella isolates by agarose gell electrophoresis.

Authors:  A F Jamieson; D A Bremner; P L Bergquist; H E Lane
Journal:  J Gen Microbiol       Date:  1979-07
View more
  45 in total

1.  Inhibitor-resistant TEM-33 beta-lactamase in a Shigella sonnei isolate.

Authors:  D Sirot; C Chanal; R Bonnet; C De Champs; L Bret
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India.

Authors:  Gururaja Perumal Pazhani; Bhaswati Sarkar; Thandavarayan Ramamurthy; S K Bhattacharya; Yoshifumi Takeda; S K Niyogi
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  Facilitated molecular typing of Shigella isolates using ERIC-PCR.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Robert H Gilman; Henry Vela; Maribel Paredes Olortegui; Cesar Banda Chavez; Maritza Calderon; Juan Perez Bao; Eric Hall; Ryan Maves; Rosa Burga; Graciela Meza Sanchez
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

4.  High genetic stability of integrons in clinical isolates of Shigella spp. of worldwide origin.

Authors:  Véronique Dubois; Marie-Pierre Parizano; Corinne Arpin; Laure Coulange; Marie-Christine Bezian; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

5.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  Molecular characteristics of Shigella spp. isolated from patients with diarrhoea in a new industrialized area of Thailand.

Authors:  M Na-Ubol; S Samosornsuk; L Von Seidlein; P Tapchaisri; M Ali; J D Clemens; W Chaicumpa
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

7.  Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection.

Authors:  Niall DeLappe; Fiona O'Halloran; Seamus Fanning; G Corbett-Feeney; T Cheasty; M Cormican
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.

Authors:  Roberto Cabrera; Joaquím Ruiz; Francesc Marco; Inés Oliveira; Margarita Arroyo; Ana Aladueña; Miguel A Usera; M Teresa Jiménez De Anta; Joaquím Gascón; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania.

Authors:  Susan C Morpeth; Nathan M Thielman; Habib O Ramadhani; John D Hamilton; Jan Ostermann; Peter R Kisenge; Humphrey J Shao; L Barth Reller; Dafrosa K Itemba; Noel E Sam; John A Bartlett; John F Shao; John A Crump
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

10.  Shigella spp. surveillance in Indonesia: the emergence or reemergence of S. dysenteriae.

Authors:  D Subekti; B A Oyofo; P Tjaniadi; A L Corwin; W Larasati; M Putri; C H Simanjuntak; N H Punjabi; J Taslim; B Setiawan; A A Djelantik; L Sriwati; A Sumardiati; E Putra; J R Campbell; M Lesmana
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.